Skip to content

H2020FP7HORIZON

Eli Lilly and Company Ltd

Country
GBUnited Kingdom
Defence projects
0
Projects, all programmes
70
As coordinator
0
EU contribution (CORDIS)
EUR 1,853,320
Active
2009 to 2025

Projects

70 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
IPIEIntelligent Assessment of Pharmaceutical in the EnvironmentFP72015ParticipantNot stated
CANCER-IDCancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in bloodFP72015ParticipantNot stated
eCHO SystemsEnhancing CHO by Mammalian Systems Biotechnology (eCHO systems)H20202015PartnerEUR 0
PSYSCANTranslating neuroimaging findings from research into clinical practiceFP72014ParticipantEUR 124,697
PRECISESADSMolecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune DiseasesFP72014ParticipantNot stated
D3i4ADDiagnostic and Drug Discovery Initiative for Alzheimer’s DiseaseH20202014ParticipantEUR 290,164
SPRINTTSarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategiesFP72014ParticipantNot stated
EBISCEuropean Bank for induced pluripotent Stem CellsFP72014ParticipantNot stated
GETREALIncorporating real-life clinical data into drug developmentFP72013ParticipantNot stated
EUPATIEuropean Patients' Academy on Therapeutic InnovationFP72012ParticipantNot stated
DIRECTDIabetes REsearCh on patient sTratificationFP72012ParticipantNot stated
EU-AIMSEuropean Autism Interventions - A Multicentre Study for Developing New MedicationsFP72012ParticipantNot stated
ETRIKSDelivering European Translational Information & Knowledge Management ServicesFP72012ParticipantNot stated
STEMBANCCStem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC)FP72012ParticipantNot stated
MIP-DILIMechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver InjuryFP72012ParticipantNot stated
OPEN PHACTSThe Open Pharmacological Concepts Triple StoreFP72011ParticipantNot stated
DDMOREDrug Disease Model ResourcesFP72011ParticipantNot stated
CRESTARPharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophreniaFP72011ParticipantNot stated
QUIC-CONCEPTQUantitative Imaging in Cancer: CONnecting CEllular Processes with TherapyFP72011ParticipantNot stated
EHR4CRElectronic Health Record systems for Clinical ResearchFP72011ParticipantNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.